glp 1 receptor agonist weight loss GLP-1 Agonists as Treatments for Type 2 Diabetes Balancing weight and muscle loss
Description
Key References Jastreboff AM, Kaplan LM, Fras JP, Wu Q, Du Y, Gurbuz S, et al
Ann Intern Med 173(4):278286
Short-term administration of the GLP-1 analog liraglutide decreases circulating leptin and increases GIP levels and these changes are associated with alterations in CNS responses to food cues: A randomized, placebo-controlled, crossover study
Avoid temperature excursions, since warm temperatures degrade peptides regardless of dose
Publication fee of this article was waived by the publisher
References [1].Buchanan TA, Xiang AH
